Vein Centers of America (VSA) is celebrating its 17th anniversary by offering a complimentary phone consultation with President and CEO David Schmiege. in vein-specific practice management, marketing and revenue cycle management initiatives nationwide. “We have the experience, flexibility, structure and size to implement results quickly and to create the culture
The U.S Food and Drug Administration has approved Boston Scientific’s VICI Venous Stent System for the treatment of iliofemoral venous obstructive disease, which occurs when the flow of blood through the veins located deep in the pelvic region becomes blocked by a blood clot or compressed by anatomical anomalies.
VECLOSE EXTENSION STUDY: Five-year outcomes prove durability, safety, efficacy of VenaSeal Closure System
By Larry Storer Five-year results from the 2019 VeClose Extension Study of the Medtronic VenaSeal Closure System demonstrate that the treatment modality is consistent, durable and safe for permanently closing veins in patients with venous reflux disease. When compared with Medtronic Radiofrequency Ablation, VenaSeal continued to show “non-inferiority”
Merz North America Inc. has regained exclusive distribution of Asclera (polidocanol) Injection in the United States to all healthcare practitioners and phlebologists treating varicose veins. Also effective April 8, AngioDynamics Inc. is no longer an authorized distributor of Asclera. All HCPs will now be able to purchase Asclera directly
Margaret Mann, MD, FACPh, will conduct the American Vein and Lymphatic Society Sclerotherapy Course Aug. 10 in Arlington, Va. The Sclerotherapy Course is a comprehensive one-day lecture series, reviewing both the theoretical and practical essentials of sclerotherapy. This course will enhance your sclerotherapy knowledge
Editor’s Note: This June 3 article is an update to an article in the June/July issue of Vein Therapy News. AngioDynamics Inc. has closed the previously announced sale of its NAMIC fluid management portfolio to Medline Industries Inc. on May 31, 2019 for $167.5 million. AngioDynamics has used a portion
When the NASDAQ Stock Market closing bell rang on May 28, it was AngioDynamics’s three most tenured employees who were doing the honors. The May 28 honor commemorated the company’s 15th anniversary on the exchange. “NASDAQ has provided AngioDynamics with a robust platform to access the public equity
By Jade Boyd Bioengineers have cleared a major hurdle on the path to 3D printing replacement organs with a breakthrough technique for bioprinting tissues. The new innovation allows scientists to create exquisitely entangled vascular networks that mimic the body’s natural passageways for blood, air, lymph and other vital fluids.
The U.S. Department of Health and Human Services (HHS) Secretary Alex Azar and Centers for Medicare & Medicaid Services (CMS) Administrator Seema Verma announced the CMS Primary Cares Initiative April 22, a new set of payment models that will transform primary care to deliver better value for patients throughout the
Healogics, the nation’s largest provider of advanced chronic wound care services, announced in March that they have added vein ablation to their in-house service offerings through a new program called Healogics VeinCare. Healogics CMO William Ennis, DO, MBA, MMM, CPE, said this program allows Healogics to provide patients with a